Skip to content
Abierto
Menu

Award notice

Safety Evaluation and Toxicology Studies and Related Services for Drug Development

75N95024D00021

National Institutes of Health, National Institutes of Health Nida. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).

View on SAM.govMarkdown

Awarded

Lovelace Biomedical Research Institute

$48,622,546.00 on the award notice, June 20, 2024, contract 75N95024D00021

Description

As published on SAM.gov.

This synopsis of contract award is published pursuant to FAR Subpart 5.3.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Lovelace Biomedical Research Institute
UEI
MBT9RXJJ7428
CAGE
3MMH4
Vendor location
Albuquerque, NM
Contract
75N95024D00021
Obligated
$0.00, potential $48,622,546
Actions
1 between June 20, 2024 and June 20, 2024
Competition
Full and Open Competition, 6 offers received
Set-aside reported
No Set Aside Used.
Described as
Safety Evaluation and Toxicology Studies and Related Services for Drug Development
Match
award number 75N95024D00021 equals the contract number; same awarding office 75N950 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 13, 2024

    Award notice, originally solicitation

    Awarded to LOVELACE BIOMEDICAL RESEARCH INSTITUTE Albuquerque for $48,622,546. SAM.gov, notice bb0161b2c102471f941b617f6c2da333

Points of contact

Also open from this buyer